ATE70305T1 - Plasmid und seine verwendung. - Google Patents

Plasmid und seine verwendung.

Info

Publication number
ATE70305T1
ATE70305T1 AT86112941T AT86112941T ATE70305T1 AT E70305 T1 ATE70305 T1 AT E70305T1 AT 86112941 T AT86112941 T AT 86112941T AT 86112941 T AT86112941 T AT 86112941T AT E70305 T1 ATE70305 T1 AT E70305T1
Authority
AT
Austria
Prior art keywords
tnf
plasmid
base sequence
dna fragment
production
Prior art date
Application number
AT86112941T
Other languages
English (en)
Inventor
Takehiro Oshima
Shoji Tanaka
Shigekazu Matsukura
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Ltd filed Critical Suntory Ltd
Application granted granted Critical
Publication of ATE70305T1 publication Critical patent/ATE70305T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/525Tumour necrosis factor [TNF]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/14Lymphokine; related peptides
    • Y10S930/144Tumor necrosis factor
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/31Linker sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT86112941T 1985-09-30 1986-09-19 Plasmid und seine verwendung. ATE70305T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP60217740A JPH0698004B2 (ja) 1985-09-30 1985-09-30 Tnf発現用新規プラスミド
EP86112941A EP0220482B1 (de) 1985-09-30 1986-09-19 Plasmid und seine Verwendung

Publications (1)

Publication Number Publication Date
ATE70305T1 true ATE70305T1 (de) 1991-12-15

Family

ID=16709008

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86112941T ATE70305T1 (de) 1985-09-30 1986-09-19 Plasmid und seine verwendung.

Country Status (7)

Country Link
US (1) US4871663A (de)
EP (1) EP0220482B1 (de)
JP (1) JPH0698004B2 (de)
KR (1) KR870003201A (de)
AT (1) ATE70305T1 (de)
AU (1) AU597902B2 (de)
DE (1) DE3682872D1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6686455B1 (en) * 1984-07-05 2004-02-03 Genentech, Inc. Tumor necrosis factor
EP0368367A1 (de) * 1984-12-21 1990-05-16 Biogen, Inc. Reinigung, Herstellung und Verwendung von Tumornekrosefaktoren
US5059530A (en) * 1985-09-30 1991-10-22 Suntory Ltd. Expression vector for human TNF
EP0247906B1 (de) * 1986-02-04 1994-12-28 Mizuno, Den'Ichi Für Antitumor-Polypeptide kodierende DNS, die Polypeptide und diese Polypeptide enthaltenden Antitumor-Wirkstoffe
US6420374B1 (en) 1990-11-30 2002-07-16 Fred Hutchinson Cancer Research Center Use of xanthines as immunosuppressants and to inhibit allograft reactions
RU2101292C1 (ru) * 1992-09-22 1998-01-10 Акционерное общество "Биофа" Способ выделения рекомбинантного человеческого альфа-фактора некроза опухоли
EP1165813A2 (de) 1999-03-24 2002-01-02 The Board Of Regents, The University Of Texas System Lineare und zirkuläre expressionselemente
US7285269B2 (en) 2002-12-02 2007-10-23 Amgen Fremont, Inc. Antibodies directed to tumor necrosis factor
JP2005132795A (ja) * 2003-10-31 2005-05-26 Genichiro Soma 抗悪性神経膠腫剤及び動物用抗悪性神経膠腫剤
US7479540B1 (en) 2003-12-22 2009-01-20 Chandan Prasad Adipomodulin and related molecules and methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0155549B1 (de) * 1984-03-06 1991-03-20 Dainippon Pharmaceutical Co., Ltd. DNS den menschlichen Tumornekrosisfaktor kodierend und das menschliche Tumornekronisfaktor-Polypeptid
US4879226A (en) * 1984-04-06 1989-11-07 Asahi Kasei Kogyo Kabushiki Kaisha Novel human physiologically active polypeptide
US4677064A (en) * 1984-11-09 1987-06-30 Cetus Corporation Human tumor necrosis factor
EP0368367A1 (de) * 1984-12-21 1990-05-16 Biogen, Inc. Reinigung, Herstellung und Verwendung von Tumornekrosefaktoren

Also Published As

Publication number Publication date
AU597902B2 (en) 1990-06-14
JPH0698004B2 (ja) 1994-12-07
EP0220482B1 (de) 1991-12-11
US4871663A (en) 1989-10-03
KR870003201A (ko) 1987-04-15
EP0220482A1 (de) 1987-05-06
AU6259586A (en) 1987-04-02
DE3682872D1 (de) 1992-01-23
JPS6277324A (ja) 1987-04-09

Similar Documents

Publication Publication Date Title
EP0238023A3 (en) Process for the production of protein products in aspergillus oryzae and a promoter for use in aspergillus
IL173399A0 (en) Circular dna molecule with conditional origin of replication which contains nucleic acid of interest and selection marker but does not encode its replication initiation protein, method for preparing the same and use thereof in gene therapy
EP0048970A3 (de) Polypeptide, Verfahren zu ihrer mikrobischen Herstellung, Zwischenprodukte dafür und diese enthaltende Zusammensetzungen
DE3682872D1 (de) Plasmid und seine verwendung.
DK600486A (da) Igg-bindingsprotein
DE3279699D1 (en) Construction of dna sequences and their use for microbial production of proteins, in particular human serum albumin
DE3379591D1 (en) Microbially prepared interferon alpha2(arg), dna sequence coding for said interferon, microorganisms containing this genetic information and process for their production
NO910797D0 (no) Dna-fragment som koder for et polypeptid med nitrilhydratase-aktivitet, en transformant inneholdende genet og en fremgangsmaate for fremstilling av amider ved bruk av transformanten.
LU90456I2 (fr) Facteur de nécrose de tumeurs procédés pour sa pr-paration compositions le contenant adn codant pour ce facteur et essai utlisant cet adn
ES551913A0 (es) Un metodo para obtener expresion de una secuencia de codificacion deseada en celulas de mamifero
EP0185444A3 (en) Cloning and expression of htlv-iii dna
AU577810B2 (en) Cloning the gene for rabbit tumor necrosis factor polypeptide
KR900009981A (ko) 아미노트랜스퍼라제의 암호화 유전자 및 유전자 구조물, 및 이 유전자를 발현하는 미생물
EP0139501A3 (de) Herstellung und Expression von Genen für Thaumatin
NO803779L (no) Rekombinant bakteriofag for heterolog kloning av bacillus mikroorganismer og fremgangsmaate for dets fremstilling
de Boer A versatile plasmid system for the study of prokaryotic transcription signals in Escherichia coli
EP0094797A3 (de) Klonierungsvektoren für die Polypeptideexpression in mikrobiellen Wirten
Moore et al. Nucleotide sequence of the argF regulatory region of Escherichia coli K-12
EP0183272A3 (en) Vector capable of efficient gene expression and utilization of such vector
DE69105768D1 (de) Verfahren zur Herstellung von Fremdprotein in Escherichia Coli.
SE8903865D0 (sv) Expression of heterologous proteins using eukaryotic cells
JPS6486875A (en) Plasmid vector containing streptomycin-sensitive gene
JPH02163087A (ja) α↓2−プラスミンインヒビター発現用プラスミド
ES8306795A1 (es) Un metodo de preparar una molecula de acido desoxirribonu- cleico (adn)

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee